JASPER Therapy for Down Syndrome
Trial Summary
What is the purpose of this trial?
This trial studies the impact of JASPER therapy, which involves one-on-one coaching for caregivers of children with Down syndrome. The goal is to improve children's play, attention, and interaction skills, as well as caregiver confidence and effectiveness. JASPER is a naturalistic developmental behavioral intervention that has been shown to improve social communication, play skills, and language skills in children.
Research Team
Eligibility Criteria
This trial is for children aged 3-6 with confirmed Trisomy 21 Down Syndrome who can walk and speak English. Their caregiver must be able to do virtual coaching or learn a behavioral curriculum. Children with mosaic/translocation Down syndrome, major hearing/vision issues, or autism cannot join.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- JASPER (Behavioral Intervention)
- Psychoeducational Curriculum (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston Children's Hospital
Lead Sponsor
Dr. Kevin B. Churchwell
Boston Children's Hospital
Chief Executive Officer since 2021
MD from Vanderbilt Medical School
Dr. Sarah Pitts
Boston Children's Hospital
Chief Medical Officer since 2019
MD from Harvard Medical School